University of Toronto company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

utoronto.ca

Founded Year

1827

Stage

Grant - II | Alive

Total Raised

$8.64M

Last Raised

$1.12M | 1 yr ago

About University of Toronto

University of Toronto is a public research university in Toronto, Ontario, Canada.

University of Toronto Headquarter Location

27 King's College Circle

Toronto, Ontario, M5S 1A1,

Canada

416-978-2011

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

University of Toronto Patents

University of Toronto has filed 7 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Archaeological artefact types
  • Biotechnology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/6/2016

4/20/2021

Experimental cancer drugs, Monoclonal antibodies, Transcription factors, Clusters of differentiation, Tyrosine kinase receptors

Grant

Application Date

1/6/2016

Grant Date

4/20/2021

Title

Related Topics

Experimental cancer drugs, Monoclonal antibodies, Transcription factors, Clusters of differentiation, Tyrosine kinase receptors

Status

Grant

Latest University of Toronto News

UCalgary researchers with the Calgary Stroke Program make another breakthrough in the treatment of stroke

Jun 29, 2022

In the largest stroke clinical trial ever run in Canada, researchers have shown Tenecteplase (TNK), a safe, well tolerated drug, commonly used as a clot buster for heart attacks, is an effective treatment for acute ischemic stroke. Led by researchers with the University of Calgary at the Foothills Medical Centre and Sunnybrook Health Sciences Centre, fully affiliated with the University of Toronto, the study included 1600 patients at hospitals throughout Canada. “It is truly an important finding that I share with my colleagues from coast to coast. Through this collaboration these findings could revolutionize stroke treatment throughout the world,” says Dr. Bijoy Menon, MD, professor at the University of Calgary, neurologist at the Foothills Medical Centre and co-principal investigator on the study. “Tenecteplase is known to be an effective clot dissolving drug. It is very easy to administer which makes it a game changer when seconds count to save brain cells,” Based on current guidelines, Alteplase (tPA) is the recommended drug for acute ischemic stroke patients. The challenge is that the drug is more complex to administer. It takes up to an hour and requires an infusion pump that needs to be monitored. The pump can be cumbersome when transporting a patient within a hospital, or to a major stroke center for treatment. “One of the reasons Tenecteplase is so effective is that in can be administered as a single immediate dose,” says Dr. Rick Swartz, MD, PhD, clinician-researcher at the University of Toronto, co-principal investigator, and stroke neurologist at Sunnybrook Health Sciences Centre. “That’s a big advantage, saving critical time and complication. TNK could potentially be administered wherever the patient is seen first, at a medical centre or small hospital,” The AcT Trial compared TNK to tPA in a randomized trial. The results published in The Lancet show that TNK worked as well as, if not better than, the current recommended drug, tPA. TNK attaches itself to the clot for a longer period of time than tPA which means that blood flow is restored faster and for a longer period of time. Along with discovering a better way to treat acute ischemic stroke, the team also established a more cost effective, and efficient way to conduct clinical trials. The trial engaged patients and their families in study design and completed all enrolments during the pandemic when health systems were under significant stress. The study involved 22 primary and comprehensive stroke centers across Canada and was supported by the Canadian Institutes of Health Research (CIHR), Alberta Strategy for Patient-Oriented Research (SPOR), Quality Improvement & Clinical Research Alberta Stroke Program (QuICR), Alberta Innovates, Heart & Stroke and the Canadian Stroke Consortium.

University of Toronto Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

University of Toronto Rank

  • When was University of Toronto founded?

    University of Toronto was founded in 1827.

  • Where is University of Toronto's headquarters?

    University of Toronto's headquarters is located at 27 King's College Circle, Toronto.

  • What is University of Toronto's latest funding round?

    University of Toronto's latest funding round is Grant - II.

  • How much did University of Toronto raise?

    University of Toronto raised a total of $8.64M.

  • Who are the investors of University of Toronto?

    Investors of University of Toronto include Government of Ontario and FedDev Ontario.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.